Видео ютуба по тегу Trial: Her2Climb

Understanding the HER2CLIMB Trial
Understanding the HER2CLIMB Trial
myTRIAList Clinical Trial: HER2CLIMB-05
myTRIAList Clinical Trial: HER2CLIMB-05
SABCS Snippet - HER2CLIMB-05 Clinical Trial Updates
SABCS Snippet - HER2CLIMB-05 Clinical Trial Updates
Understanding HER2CLIMB Clinical Trial
Understanding HER2CLIMB Clinical Trial
Краткий обзор SABCS: Результаты III фазы клинических испытаний HER2CLIMB-05
Краткий обзор SABCS: Результаты III фазы клинических испытаний HER2CLIMB-05
HER2CLIMB-05: the role of tucatinib in HER2-positive metastatic breast cancer
HER2CLIMB-05: the role of tucatinib in HER2-positive metastatic breast cancer
HER2CLIMB-05: tucatinib improves progression-free survival in HER2+ metastatic breast cancer
HER2CLIMB-05: tucatinib improves progression-free survival in HER2+ metastatic breast cancer
HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer
HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer
HER2CLIMB-02 Trial Regimen Toxicities and Impact
HER2CLIMB-02 Trial Regimen Toxicities and Impact
HER2CLIMB and NALA Trials: R/R HER2+ mBC
HER2CLIMB and NALA Trials: R/R HER2+ mBC
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC
HER2CLIMB and NALA Trials: R/R HER2+ mBC
HER2CLIMB and NALA Trials: R/R HER2+ mBC
HER2+ mBC: Systemic Therapies and HER2CLIMB-02 Trial
HER2+ mBC: Systemic Therapies and HER2CLIMB-02 Trial
Dr. Murthy on HER2CLIMB Trial Results in HER2+ Breast Cancer
Dr. Murthy on HER2CLIMB Trial Results in HER2+ Breast Cancer
Breast Cancer Breakthroughs: HER2CLIMB-05 Trial
Breast Cancer Breakthroughs: HER2CLIMB-05 Trial
Dr. Hamilton on the HER2CLIMB Trial in Metastatic HER2+ Breast Cancer
Dr. Hamilton on the HER2CLIMB Trial in Metastatic HER2+ Breast Cancer
The HER2CLIMB-02 Trial Design, Results and Implications
The HER2CLIMB-02 Trial Design, Results and Implications
HER2CLIMB: tucatinib with trastuzumab and capecitabine for HER2+ breast cancer with brain metastases
HER2CLIMB: tucatinib with trastuzumab and capecitabine for HER2+ breast cancer with brain metastases
HER2CLIMB: tucatinib efficacious against brain metastases in patients with HER2+ breast cancer
HER2CLIMB: tucatinib efficacious against brain metastases in patients with HER2+ breast cancer
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer